PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Rüeger, S.* ; Gruener, E.* ; Wang, D.* ; Abdool, F.S.* ; Ober, V.* ; Vallée, T.* ; Stirner, R.* ; Conca, R.* ; Andrä, I.* ; Rogers, L.* ; Zahn, R.* ; Gersbacher, E.* ; Eger, J.* ; Pauli, R.* ; Postel, N.* ; Spinner, C.D.* ; Vehreschild, J.J.* ; Stecher, M.* ; Nitschko, H.* ; Eberle, J.* ; Bogner, J.R.* ; Seybold, U.* ; Draenert, R.* ; Leslie, A.* ; Kløverpris, H.N.* ; Geldmacher, C.* ; Muenchhoff, M.* ; Held, K. ; Roider, J.*

Early treatment and PD1 inhibition enhance HIV-specific functionality of follicular CD8+ T cells.

JCI insight 10:e180309 (2025)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
People living with HIV treated during acute infection are the group for whom achieving functional cure appears most viable. Follicular CD8+ T cells could contribute to HIV reservoir clearance by accessing B cell follicles through CXCR5 expression. This study examines peripheral follicular CD8+ T cells using flow cytometry, transcriptome analyses, and functional assays in people treated during acute (n = 37) and chronic (n = 18) infection, as well as in individuals naturally controlling HIV (n = 20) and living without HIV (n = 10). Our results reveal that early, as opposed to late, treatment initiation preserves antiviral effector functions of follicular CD8+ T cells, which are further enhanced by PD1 inhibition. We also identify a correlation between follicular CD8+ T cells and intact proviral HIV DNA levels in acute, but not chronic, infection. Longitudinal transcriptomic analysis of peripheral effector cells after 48 weeks of suppressive therapy indicated traits of recent antigen exposure, suggesting potential recirculation into lymphoid tissue. These findings underscore the pivotal role of follicular CD8+ T cells in anti-HIV responses and support investigating targeted cure strategies, such as anti-PD1 therapy, especially in individuals initiating treatment during acute infection.
Impact Factor
Scopus SNIP
Altmetric
6.100
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Aids/hiv ; Adaptive Immunity ; Immunology ; T Cells; Cd8(+) T-cells; Immunodeficiency Virus-infection; Immune Checkpoint Blockade; Lymphocyte Response; Down-regulation; Plasma Viremia; Siv Viremia; Rna-seq; Ex-vivo; In-vivo
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 2379-3708
e-ISSN 2379-3708
Zeitschrift JCI insight
Quellenangaben Band: 10, Heft: 7, Seiten: , Artikelnummer: e180309 Supplement: ,
Verlag Clarivate
Verlagsort Ann Arbor, Michigan
Begutachtungsstatus Peer reviewed
Institut(e) Research Unit Global Health (UGH)
POF Topic(s) 30205 - Bioengineering and Digital Health
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-540001-003
Förderungen Wellcome Trust
Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) - Science for Africa Foundation
NIH
German Federal Ministry of Education and Research (BMBF) through DZIF
Bavarian Gender Equality Grant
Else Kroner-Fresenius-Stiftung (EKFS)
UK Foreign, Commonwealth & Development Office
European Union

Gilead Sciences Inc.
Bill & Melinda Gates Foundation
DZIF
DOI 10.1172/jci.insight.180309
WOS ID 001489740000001
Scopus ID 105002419079
PubMed ID 40197363
Erfassungsdatum 2025-05-10
[➜Korrektur melden]